Latest News about REGN
Recent news which mentions REGN
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
From Benzinga
From Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
October 18, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
From Benzinga
13 Analysts Have This to Say About Regeneron Pharmaceuticals
October 17, 2022
Tickers
REGN
From Benzinga
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
From Motley Fool
From Benzinga
Moderna, Eli Lilly And This Biotechnology Stock Insiders Are Selling
October 10, 2022
From Benzinga
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
From InvestorPlace
2 Top Healthcare Stocks to Buy Right Now
October 08, 2022
From Motley Fool
Eaton, Wynn Resorts, Lamar Advertising And This Pharma Company Are CNBC's Final Trades
October 06, 2022
From Benzinga
Apple Short Sellers Made $2B In Profits In September, And Shorts In This Biotech Stock Lost $307M
October 05, 2022
From Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 04, 2022
From Motley Fool
13 Analysts Have This to Say About Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
From Benzinga
What 13 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
From Benzinga
Hopeful Golden Cross Forms On Regeneron Pharmaceuticals's Chart
October 03, 2022
Tickers
REGN
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
September 29, 2022
From Benzinga
Ocular Therapeutix's Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea
September 27, 2022
From Benzinga
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
The Top 5 Stocks Cathie Wood Is Buying This Week
September 23, 2022
From InvestorPlace
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
September 20, 2022
Tickers
REGN
From Benzinga
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.